Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Nadia P. Ewing, MD
Healthcare Provider Clinical Professor of Pediatrics
Pediatric Hemophilia Treatment Center
City of Hope
1500 East Duarte Road
Duarte, California, United States
Nadia Ewing, M.D., is a clinical professor of Pediatrics and director of the Pediatric Hemophilia Treatment Center at City of Hope, where she also serves as director of the Sickle Cell Program and Pediatric Hematology Consultations. Dr. Ewing earned her medical degree at the University of Southern California (USC) in Los Angeles. She completed an internship and residency in pediatrics, followed by a fellowship in Pediatric Hematology/Oncology at the Los Angeles County/USC Medical Center.
Dr. Ewing is a member of the International Society on Thrombosis and Haemostasis, the Hemostasis and Thrombosis Research Society, the American Society of Hematology, The American Society of Pediatric Hematology/Oncology and the World Federation of Hemophilia. Her research interests include gene therapy in hemophilia, management of inhibitors in hemophilia, and genetics of inhibitor formation in hemophilia. She has written articles in The New England Journal of Medicine, the Journal of Pediatric Hematology/Oncology and Haemophilia. Dr. Ewing has presented abstracts for the American Society of Hematology, ISTH, and the Hemostasis and Thrombosis Research Society.
+myBinderRelated Content
-
Executive functioning and health-related quality of life in pediatric sickle cell diseaseResearch consistently indicates that chi...
-
Donna J. Ezell, RNDonna is the Clinical Director at Arkans...
-
DDCF Awards $6 Million for Sickle Cell Disease ResearchThe Doris Duke Charitable Foundation has...
-
Seethal Jacob, MDDr. Seethal Jacob is a pediatric hematol...
-
Lifespan Comprehensive Sickle Cell CenterThe Lifespan Comprehensive Sickle Cell C...
-
Episodic Patterns of High Emergency Department Utilization Among Sickle Cell Disease PatientsBackground: High utilization of emergenc...
-
Sancilio Pharmaceuticals Company, Inc. (SPCI) Receives Rare Pediatric Disease Designation From the US Food and Drug ...Sancilio Pharmaceuticals Company, Inc. (...
